Disparities Between Teleretinal Imaging Findings and Patient-Reported Diabetic Retinopathy Status and Follow-up Eye Care Interval: A 10-Year Prospective Study
- PMID: 38457639
- PMCID: PMC11116909
- DOI: 10.2337/dc23-2282
Disparities Between Teleretinal Imaging Findings and Patient-Reported Diabetic Retinopathy Status and Follow-up Eye Care Interval: A 10-Year Prospective Study
Abstract
Objective: To assess self-reported awareness of diabetic retinopathy (DR) and concordance of eye examination follow-up compared with findings from concurrent retinal images.
Research design and methods: We conducted a prospective observational 10-year study of 26,876 consecutive patients with diabetes who underwent retinal imaging during an endocrinology visit. Awareness and concordance were evaluated using questionnaires and retinal imaging.
Results: Awareness information and gradable images were available in 25,360 patients (94.3%). Severity of DR by imaging was as follows: no DR (n = 14,317; 56.5%), mild DR (n = 6,805; 26.8%), or vision-threatening DR (vtDR; n = 4,238; 16.7%). In the no, mild, and vtDR groups, 96.7%, 88.5%, and 54.9% of patients, respectively, reported being unaware of any prior DR. When DR was present, reporting no prior DR was associated with shorter diabetes duration, milder DR, last eye examination >1 year before, no dilation, no scheduled appointment, and less specialized provider (all P < 0.001). Among patients with vtDR, 41.2%, 58.1%, and 64.2% did not report being aware of any DR and follow-up was concordant with current DR severity in 66.7%, 41.3%, and 25.4% (P < 0.001) of patients when prior examination was performed by a retinal specialist, nonretinal ophthalmologist, or optometrist (P < 0.001), respectively.
Conclusions: Substantial discrepancies exist between DR presence, patient awareness, and concordance of follow-up across all DR severity levels. These discrepancies are present across all eye care provider types, with the magnitude influenced by provider type. Therefore, patient self-report should not be relied upon to reflect DR status. Modification of medical care and education models may be necessary to enhance retention of ophthalmic knowledge in patients with diabetes and ensure accurate communication between all health care providers.
© 2024 by the American Diabetes Association.
Comment in
-
Measuring Outcomes of Diabetic Retinopathy Screening: What Is Important?Diabetes Care. 2024 Jun 1;47(6):930-932. doi: 10.2337/dci24-0021. Diabetes Care. 2024. PMID: 38768335 No abstract available.
Similar articles
-
Follow-Up Compliance for Patients Diagnosed with Diabetic Retinopathy After Teleretinal Imaging in Primary Care.Telemed J E Health. 2021 Mar;27(3):303-307. doi: 10.1089/tmj.2019.0264. Epub 2020 Jun 15. Telemed J E Health. 2021. PMID: 32543302
-
The Prevalence of Diabetic Retinopathy in Australian Adults with Self-Reported Diabetes: The National Eye Health Survey.Ophthalmology. 2017 Jul;124(7):977-984. doi: 10.1016/j.ophtha.2017.02.004. Epub 2017 Mar 15. Ophthalmology. 2017. PMID: 28318640
-
Prevalence of diabetic retinopathy and self-reported barriers to eye care among patients with diabetes in the emergency department: the diabetic retinopathy screening in the emergency department (DRS-ED) study.BMC Ophthalmol. 2022 May 27;22(1):237. doi: 10.1186/s12886-022-02459-y. BMC Ophthalmol. 2022. PMID: 35624427 Free PMC article.
-
Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study.Br J Ophthalmol. 2015 Dec;99(12):1614-21. doi: 10.1136/bjophthalmol-2014-306492. Epub 2015 May 7. Br J Ophthalmol. 2015. PMID: 25953847
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
Cited by
-
Protective Effects of Bioactive Compound-Derived Nanoparticle Against Diabetic Retinopathy Through the Modulation of the NF-κB Signaling Pathway.ACS Omega. 2024 Jun 5;9(24):26267-26274. doi: 10.1021/acsomega.4c02066. eCollection 2024 Jun 18. ACS Omega. 2024. PMID: 38911745 Free PMC article.
-
Association of Neighborhood Socioeconomic Disadvantage with Proliferative Diabetic Retinopathy.Ophthalmol Retina. 2025 Feb;9(2):98-104. doi: 10.1016/j.oret.2024.10.012. Epub 2024 Oct 18. Ophthalmol Retina. 2025. PMID: 39426522
References
-
- Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4–14 - PubMed
-
- Brechner RJ, Cowie CC, Howie LJ, Herman WH, Will JC, Harris MI. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 1993;270:1714–1718 - PubMed
-
- Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology 2003;110:1952–1959 - PubMed
-
- Paz SH, Varma R, Klein R, Wu J; Los Angeles Latino Eye Study Group . Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study. Ophthalmology 2006;113:1372–1377 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical